The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of the combination of durvalumab (MEDI4736) plus olaparib (AZD2281) administered prior to surgery in the molecular profile of resectable urothelial bladder cancer: NEODURVARIB Trial.
 
Juan Francisco Rodriguez-Moreno
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Novartis; Rain Therapeutics (Inst)
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Janssen; MSD; Novartis; Pfizer; Roche
Research Funding - Amgen (Inst); Astellas Oncology (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Ipsen (Inst); Janssen (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - Astellas Oncology; AstraZeneca; Bristol-Myers Squibb; MSD; Novartis; Pfizer; Roche
 
Guillermo de Velasco
Honoraria - Ipsen; Pfizer
Consulting or Advisory Role - Astellas Medivation; Bayer; Bristol-Myers Squibb; Ipsen; Janssen; MSD; MSD; Novartis; Pfizer
Research Funding - Ipsen
Other Relationship - Janssen
 
Inmaculada Bravo Fernandez
No Relationships to Disclose
 
Carlos Alvarez-Fernandez
No Relationships to Disclose
 
Ricardo Fernandez
No Relationships to Disclose
 
Sergio Vazquez-Estevez
Consulting or Advisory Role - AstraZeneca Spain; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; MSD Oncology; Novartis; Pfizer; Roche Pharma AG; Sanofi
Speakers' Bureau - AstraZeneca Spain; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Novartis; Roche
Travel, Accommodations, Expenses - AstraZeneca Spain; Roche Pharma AG
 
Juan Antonio Virizuela
No Relationships to Disclose
 
Pablo Gajate
Consulting or Advisory Role - Ipsen
Speakers' Bureau - IPSEN; Novartis; Pfizer
Travel, Accommodations, Expenses - Ipsen; Pfizer
 
Albert Font
No Relationships to Disclose
 
Nuria Lainez
No Relationships to Disclose
 
Arantzazu Martínez Barquín García
No Relationships to Disclose
 
Sergio Ruiz-Llorente
No Relationships to Disclose
 
Luis Beltran
No Relationships to Disclose
 
Cristina Rodríguez-Antona
No Relationships to Disclose
 
Pedro Berraondo
No Relationships to Disclose
 
Jesús García-Donas
No Relationships to Disclose